Rigel Pharmaceuticals, Inc. (RIGL)
Market Closed
27 Jul, 20:00
$
37. 39
+0.65
+1.7692%
$
691.79M Market Cap
- P/E Ratio
- Div Yield
222,643 Volume
-0.06 Eps
$ 36.74
Previous Close 
Want to track RIGL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 1.33 | - |
| | | 0.93 | - |
| | | 1.42 | - |
| | | 0.09 | 0.63 |
| | | - | - |
| | | 0.06 | - |
| | | - | - |
| | | - | - |
| | | - | 0 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
RIGL Earnings Reports FAQ
What is the earnings per share (EPS) for RIGL?
The current EPS is -0.06.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 14,900%, reflecting the RIGL's performance and NASDAQ (NGS) market conditions.
When is the next earnings release date?
Rigel Pharmaceuticals, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Rigel Pharmaceuticals, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RIGL at this time, as Rigel Pharmaceuticals, Inc has no recent EPS data to calculate it.
